Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.4M
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
25.9M
-
Shares change
-
-191K
-
Total reported value, excl. options
-
$522M
-
Value change
-
-$3.02M
-
Number of buys
-
47
-
Number of sells
-
-64
-
Price
-
$20.11
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q4 2020
139 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q4 2020.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.9M shares
of 46.4M outstanding shares and own 55.94% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.14M shares), FEDERATED HERMES, INC. (3.23M shares), VANGUARD GROUP INC (2.48M shares), DIMENSIONAL FUND ADVISORS LP (1.81M shares), Invesco Ltd. (1.4M shares), STATE STREET CORP (1.28M shares), GEODE CAPITAL MANAGEMENT, LLC (574K shares), GOLDMAN SACHS GROUP INC (553K shares), FULLER & THALER ASSET MANAGEMENT, INC. (546K shares), and NORTHERN TRUST CORP (489K shares).
This table shows the top 124 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.